يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"2-Ring::Indoles"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Grande E Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain. Alonso-Gordoa T Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. Reig O Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Esteban E Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. Castellano D Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. Garcia-Del-Muro X Medical Oncology, Institut Català d’Oncologia (ICO Bellvitge) Idibell, University of Barcelona, Barcelona, Spain. González Rodríguez M Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: ESMO Open;7(2); https://doi.org/10.1016/j.esmoop.2022.100463Test; Grande E, Alonso-Gordoa T, Reig O, Esteban E, Castellano D, Garcia-del-Muro X, et al. Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy. ESMO Open. 2022 Apr;7(2):100463.; https://hdl.handle.net/11351/9666Test; 000797892800020

  2. 2

    المساهمون: Institut Català de la Salut, [Grande E] Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain. [Alonso-Gordoa T] Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Reig O] Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Esteban E] Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. [Castellano D] Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. [Garcia-Del-Muro X] Medical Oncology, Institut Català d’Oncologia (ICO Bellvitge) Idibell, University of Barcelona, Barcelona, Spain. [González Rodríguez M] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    Scientia

    مصطلحات موضوعية: Male, Cancer Research, Indoles, compuestos heterocíclicos::compuestos heterocíclicos con anillos de fusión::compuestos heterocíclicos de 2 anillos::indoles [COMPUESTOS QUÍMICOS Y DROGAS], sunitinib, neoplasias::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales::carcinoma de células renales [ENFERMEDADES], Ronyons - Càncer - Tractamemt, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Càncer de ronyó, immune checkpoint inhibitors, Sunitinib, Humans, Prospective Studies, Other subheadings::/therapeutic use [Other subheadings], Carcinoma, Renal Cell, Otros calificadores::/uso terapéutico [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Enzyme inhibitors, metastatic renal carcinoma, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Kidney Neoplasms, Renal cancer, Oncology, Inhibidors enzimàtics, second-line treatment, Neoplasms::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell [DISEASES], Avaluació de resultats (Assistència sanitària), Female, Heterocyclic Compounds::Heterocyclic Compounds, Fused-Ring::Heterocyclic Compounds, 2-Ring::Indoles [CHEMICALS AND DRUGS]

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المساهمون: Capdevila,J Medical Oncology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Spain. Sevilla,I Medical Oncology Department, Virgen de la Victoria University Hospital, Málaga, Spain. Alonso,V Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain. Antón Aparicio,L Medical Oncology Department, University Hospital Complex, As Xubias, A Coruña, Spain. Jiménez Fonseca,P Medical Oncology Department, Asturias Central University Hospital, Oviedo, Spain. Grande,E Medical Oncology Department, Ramón y Cajal University Hospita, Madrid, Spain. Reina,JJ Medical Oncology Department, Virgen Macarena University Hospital, Sevilla, Spain. Manzano,JL Medical Oncology Department, Catalan Oncology Institute (ICO-Badalona), Germans Trias i Pujol University Hospital, Barcelona, Spain. Alonso Lájara,JD Medical Oncology Department, Virgen de la Arrixaca University Hospital, Murcia, Spain. Barriuso,J Medical Oncology Department, La Paz University Hospital, Madrid, Spain. Castellano,D Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain. Medina,J Medical Oncology Department, Toledo Hospital Complex, Toledo, Spain. López,C Medical Oncology Department, La Fe University Hospital, Valencia, Spain. Carrera,S Medical Oncology Department, Cruces University Hospital, Vizcaya, Spain. Crespo,G Medical Oncology Department, Burgos University Hospital, Burgos, Spain. Fuster,J Medical Oncology Department, Son Dureta University Hospital, Palma de Mallorca, Spain. Munarriz,J Medical Oncology Department, Castellón Provincial Hospital Consortium, Castellón de la Plana, Spain. García Alfonso,P Medical Oncology Department, Gregorio Marañon Hospital, Madrid, Spain.

    مصطلحات موضوعية: Lanreotide, Neuroendocrine tumours, Sunitinib, Everolimus, Somatostatin analogues, Clinical practice, Cross-sectional analysis, Combination treatment, Tumores Neuroendocrinos, Péptidos Cíclicos, Estudios Prospectivos, Sirolimus, Somatostatina, Inhibidores de la Angiogénesis, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Angiogenesis Modulating Agents::Angiogenesis Inhibitors, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles, Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neuroendocrine Tumors, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Peptides, Cyclic, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies, 1-Ring::Azoles::Pyrroles, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies, Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Lactones::Macrolides::Sirolimus

    وصف الملف: application/pdf

    العلاقة: http://www.biomedcentral.com/1471-2407/15/495/abstractTest; Capdevila J, Sevilla I, Alonso V, Antón Aparicio L, Jiménez Fonseca P, Grande E, et al. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis. BMC Cancer. 2015; 15:495; http://hdl.handle.net/10668/1984Test; PMC4490650

  4. 4
    دورية أكاديمية

    المساهمون: Larkin,J Royal Marsden Hospital, London. Ascierto,PA Istituto Nazionale Tumori Fondazione G. Pascale, Naples,Italy. Dréno,B Hôtel Dieu Place Alexis Ricordeau,Nantes,France. Atkinson,V Princess Alexandra Hospital, Woolloongabba, QLD,Australia. Liszkay,G National Institute of Oncology, Budapest, Hungary. Maio,M Azienda Ospedaliera Universitaria Senese, Siena,Italy. Mandalà,M Papa Giovanni XXIII Hospital, Bergamo,Italy. Demidov,L Blokhin Russian Cancer Research Center, Moscow,Russia. Stroyakovskiy,D Moscow City Oncology Hospital 62, Krasnogorsk, Russia. Thomas,L Centre Hospitalier Lyon Sud, Pierre-Bénite,France. de la Cruz-Merino,L Hospital Universitario Virgen Macarena, Seville, Spain. Dutriaux,C Hôpital Saint André, Bordeaux,France. Garbe,C University of Tübingen, Tübingen, Germany. Sovak,MA, Chang,I, Choong,N, Hack,SP Genentech, South San Francisco. Ribas,A Jonsson Comprehensive Cancer Center at the University of California, Los Angeles., Supported by F. Hoffmann–La Roche/Genentech.

    مصطلحات موضوعية: Indoles, Sulfonamides, Proto-oncogene proteins B-raf, MAP quinasa quinasa 1, Azetidines, Piperidinas, Sulfonamidas, Azetidinas, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azetines::Azetidines, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, 2-Ring::Indoles, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate, Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Serine-Threonine Kinases::Mitogen-Activated Protein Kinase Kinases::MAP Kinase Kinase 1, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Nevi and Melanomas::Melanoma, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation, 1-Ring::Piperidines, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Neoplasm Proteins::Oncogene Proteins::Proto-Oncogene Proteins::raf Kinases::Proto-Oncogene Proteins B-raf, Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Sulfones::Sulfonamides, Medical Subject Headings::Information Science::Information Science::Data Collection::Vital Statistics::Mortality::Survival Rate, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult

    وصف الملف: application/pdf

    العلاقة: Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N. Engl. J. Med. 2014; 371(20):1867-76; http://hdl.handle.net/10668/2159Test

  5. 5

    المساهمون: [Espinosa Bosch, M, Asensi Díez, R, García Agudo,S] Hospital Regional de Málaga, Málaga. [Clopés Estela,A] Hospital Duran I Reynals. Institut Català d’Oncologia. Hospitalet, Barcelona. Spain.

    المصدر: Farmacia Hospitalaria, Vol 40, Iss 4, Pp 316-327 (2016)
    Farmacia Hospitalaria v.40 n.4 2016
    SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
    instname

    مصطلحات موضوعية: Cáncer de pulmón no microcítico, Indoles, Lung Neoplasms, Anatomy::Digestive System::Liver [Medical Subject Headings], Calidad de vida, Cost-Benefit Analysis, lcsh:Medicine, lcsh:RS1-441, Docetaxel, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Alicyclic::Cycloparaffins::Cyclodecanes::Taxoids [Medical Subject Headings], Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma [Medical Subject Headings], Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles [Medical Subject Headings], Recurrencia local de neoplasia, Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [Medical Subject Headings], Hígado, Information Science::Information Science::Communications Media::Publications::Books::Reference Books::Formularies as Topic::Formularies, Hospital [Medical Subject Headings], Adulto, Humanos, Treatment Outcome, Taxoides, Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Disease-Free Survival [Medical Subject Headings], Taxoids, Nintedanib, Incidencia, Coste-efectividad, Neutropenia, Antineoplastic Agents, Adenocarcinoma, Carcinoma de pulmón de células no pequeñas, Disease-Free Survival, lcsh:Pharmacy and materia medica, Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Incidence [Medical Subject Headings], Disciplines and Occupations::Social Sciences::Quality of Life [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Humans, Supervivencia sin enfermedad, lcsh:R, Antineoplastic Agents, Phytogenic, Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Neoplastic Processes::Neoplasm Recurrence, Local [Medical Subject Headings], Formularios de hospitales, Análisis costo-beneficio, Non small cell lung cancer, Cost-effectiveness, Docetaxe

    وصف الملف: application/pdf; text/html

  6. 6

    المساهمون: [Capdevila,J] Medical Oncology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Spain. [Sevilla,I] Medical Oncology Department, Virgen de la Victoria University Hospital, Málaga, Spain. [Alonso,V] Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain. [Antón Aparicio,L] Medical Oncology Department, University Hospital Complex, As Xubias, A Coruña, Spain. [Jiménez Fonseca,P] Medical Oncology Department, Asturias Central University Hospital, Oviedo, Spain. [Grande,E] Medical Oncology Department, Ramón y Cajal University Hospita, Madrid, Spain. [Reina,JJ] Medical Oncology Department, Virgen Macarena University Hospital, Sevilla, Spain. [Manzano,JL] Medical Oncology Department, Catalan Oncology Institute (ICO-Badalona), Germans Trias i Pujol University Hospital, Barcelona, Spain. [Alonso Lájara,JD] Medical Oncology Department, Virgen de la Arrixaca University Hospital, Murcia, Spain. [Barriuso,J] Medical Oncology Department, La Paz University Hospital, Madrid, Spain. [Castellano,D] Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain. [Medina,J] Medical Oncology Department, Toledo Hospital Complex, Toledo, Spain. [López,C] Medical Oncology Department, La Fe University Hospital, Valencia, Spain. [Carrera,S] Medical Oncology Department, Cruces University Hospital, Vizcaya, Spain. [Crespo,G] Medical Oncology Department, Burgos University Hospital, Burgos, Spain. [Fuster,J] Medical Oncology Department, Son Dureta University Hospital, Palma de Mallorca, Spain. [Munarriz,J] Medical Oncology Department, Castellón Provincial Hospital Consortium, Castellón de la Plana, Spain. [García Alfonso,P] Medical Oncology Department, Gregorio Marañon Hospital, Madrid, Spain.

    المصدر: Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    BMC Cancer
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    RUC. Repositorio da Universidade da Coruña
    instname

    مصطلحات موضوعية: Oncology, Male, Cancer Research, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings], medicine.medical_treatment, humanos, Sunitnib, adolescente, Kaplan-Meier Estimate, Neuroendocrine tumors, Pharmacology, Somatostatin analogues, Clinical practice, Lanreotide, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Neuroendocrine tumours, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, tumores neuroendocrinos, Diseases::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Pancreatic Neoplasms::Carcinoma, Islet Cell::Somatostatinoma [Medical Subject Headings], antineoplásicos, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles [Medical Subject Headings], mediana edad, Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings], Aged, 80 and over, anciano, protocolos de quimioterapia antineoplásica combinada, Estudios Prospectivos, Middle Aged, adulto, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings], adulto joven, Neuroendocrine Tumors, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Angiogenesis Modulating Agents::Angiogenesis Inhibitors [Medical Subject Headings], Female, Somatostatin, medicine.drug, Research Article, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neuroendocrine Tumors [Medical Subject Headings], Adult, estimación de Kaplan-Meier, medicine.medical_specialty, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies [Medical Subject Headings], Adolescent, Check Tags::Male [Medical Subject Headings], Antineoplastic Agents, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Pyrroles [Medical Subject Headings], Peptides, Cyclic, Péptidos Cíclicos, Young Adult, Internal medicine, Genetics, medicine, Humans, Everolimus, Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Peptides, Cyclic [Medical Subject Headings], Aged, Retrospective Studies, Sirolimus, Chemotherapy, Inhibidores de la Angiogénesis, business.industry, estudios retrospectivos, Retrospective cohort study, medicine.disease, Chemicals and Drugs::Organic Chemicals::Lactones::Macrolides::Sirolimus [Medical Subject Headings], Clinical trial, Somatostatina, somatostatina, Cross-Sectional Studies, chemistry, Combination treatment, péptidos, Tumores Neuroendocrinos, Cross-sectional analysis, business, Peptides, estudios transversales

    وصف الملف: application/pdf

  7. 7

    المساهمون: [Larkin,J] Royal Marsden Hospital, London.[Ascierto,PA] Istituto Nazionale Tumori Fondazione G. Pascale, Naples,Italy. [Dréno,B] Hôtel Dieu Place Alexis Ricordeau,Nantes,France. [Atkinson,V] Princess Alexandra Hospital, Woolloongabba, QLD,Australia. [Liszkay,G] National Institute of Oncology, Budapest, Hungary. [Maio,M] Azienda Ospedaliera Universitaria Senese, Siena,Italy. [Mandalà,M] Papa Giovanni XXIII Hospital, Bergamo,Italy. [Demidov,L] Blokhin Russian Cancer Research Center, Moscow,Russia. [Stroyakovskiy,D] Moscow City Oncology Hospital 62, Krasnogorsk, Russia. [Thomas,L] Centre Hospitalier Lyon Sud, Pierre-Bénite,France. [de la Cruz-Merino,L] Hospital Universitario Virgen Macarena, Seville, Spain. [Dutriaux,C] Hôpital Saint André, Bordeaux,France. [Garbe,C] University of Tübingen, Tübingen, Germany. [Sovak,MA, Chang,I, Choong,N, Hack,SP] Genentech, South San Francisco.[Ribas,A] Jonsson Comprehensive Cancer Center at the University of California, Los Angeles., Supported by F. Hoffmann–La Roche/Genentech.

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Indoles, Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings], Information Science::Information Science::Data Collection::Vital Statistics::Mortality::Survival Rate [Medical Subject Headings], Azetidinas, Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Serine-Threonine Kinases::Mitogen-Activated Protein Kinase Kinases::MAP Kinase Kinase 1 [Medical Subject Headings], Check Tags::Male [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Internal medicine, medicine, Piperidinas, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Vemurafenib, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles [Medical Subject Headings], Survival rate, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival [Medical Subject Headings], Diseases::Neoplasms::Neoplasms by Histologic Type::Nevi and Melanomas::Melanoma [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [Medical Subject Headings], Cobimetinib, Trametinib, Sulfonamides, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate [Medical Subject Headings], business.industry, MEK inhibitor, Melanoma, Sulfonamidas, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azetines::Azetidines [Medical Subject Headings], Binimetinib, Dabrafenib, General Medicine, medicine.disease, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Piperidines [Medical Subject Headings], Surgery, Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Sulfones::Sulfonamides [Medical Subject Headings], MAP quinasa quinasa 1, chemistry, Check Tags::Female [Medical Subject Headings], Proto-oncogene proteins B-raf, Azetidines, business, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Neoplasm Proteins::Oncogene Proteins::Proto-Oncogene Proteins::raf Kinases::Proto-Oncogene Proteins B-raf [Medical Subject Headings], medicine.drug

    وصف الملف: application/pdf

  8. 8

    المساهمون: [Valdivielso Felices,P, García-Arias,C, Sánchez-Chaparro,MA, González Santos,P] Lipids Unit, Department of Medicine, Hospital Virgen de la Victoria, Malaga and Department of Medicine & Dermatology, University of Malaga, Malaga, Spain. [Rioja,J] Department of Medicine & Dermatology, University of Málaga, Málaga, Spain., This study was financed by a Ferrer-Novag 2007 grant.

    المصدر: Cardiovascular Diabetology, Vol 8, Iss 1, p 1 (2009)
    Cardiovascular Diabetology

    مصطلحات موضوعية: Blood Glucose, Male, Very low-density lipoprotein, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Cardiovascular Agents::Antihypertensive Agents [Medical Subject Headings], lcsh:Diseases of the circulatory (Cardiovascular) system, Indoles, Apolipoprotein B, Hiperlipidemia Familiar Combinada, Endocrinology, Diabetes and Metabolism, Hyperlipidemia, Familial Combined, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Nutrition Therapy::Diet Therapy [Medical Subject Headings], Blood Pressure, Apolipoproteína B-48, Diabetes Mellitus Tipo 2, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Chemicals and Drugs::Lipids::Fats::Dietary Fats::Dietary Fats, Unsaturated::Fatty Acids, Omega-3::Eicosapentaenoic Acid [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Fatty Acids, Monounsaturated, chemistry.chemical_compound, Study Protocol, Terapia Combinada, Hyperlipidemia, Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings], Ácidos Grasos Monoinsaturados, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Indoles [Medical Subject Headings], Hypolipidemic Agents, biology, Hipolipemiantes, Middle Aged, Presión Arterial, Eicosapentaenoic acid, Combined Modality Therapy, Lipids, Drug Combinations, Eicosapentaenoic Acid, Docosahexaenoic acid, Lípidos, Hypertension, Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Monounsaturated [Medical Subject Headings], Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2 [Medical Subject Headings], Hemoglobina A Glucosilada, Female, lipids (amino acids, peptides, and proteins), Ácidos Docosahexaenoicos, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Combined Modality Therapy [Medical Subject Headings], Diet, Reducing, Docosahexaenoic Acids, Check Tags::Male [Medical Subject Headings], Chemicals and Drugs::Lipids::Lipoproteins::Apolipoproteins::Apolipoproteins B::Apolipoprotein B-48 [Medical Subject Headings], Chemicals and Drugs::Lipids [Medical Subject Headings], Antihipertensivos, Ácido Eicosapentaenoico, Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings], Glucemia, Chemicals and Drugs::Carbohydrates::Glycosides::Hemoglobin A, Glycosylated [Medical Subject Headings], Internal medicine, Hipertensión, Phenomena and Processes::Circulatory and Respiratory Physiological Phenomena::Cardiovascular Physiological Phenomena::Hemodynamics::Blood Pressure [Medical Subject Headings], medicine, Humans, Hypoglycemic Agents, Fluvastatin, Antihypertensive Agents, Omacor, Glycated Hemoglobin, Triglyceride, Cholesterol, business.industry, Chemicals and Drugs::Lipids::Fats::Dietary Fats::Dietary Fats, Unsaturated::Fatty Acids, Omega-3::Docosahexaenoic Acids [Medical Subject Headings], medicine.disease, Combinación de Medicamentos, Endocrinology, chemistry, Check Tags::Female [Medical Subject Headings], Diabetes Mellitus, Type 2, lcsh:RC666-701, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Hypolipidemic Agents [Medical Subject Headings], biology.protein, Dietoterapia, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings], business, Apolipoprotein B-48, Diseases::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Metabolism, Inborn Errors::Lipid Metabolism, Inborn Errors::Hyperlipidemia, Familial Combined [Medical Subject Headings], Chemicals and Drugs::Carbohydrates::Monosaccharides::Hexoses::Glucose::Blood Glucose [Medical Subject Headings]

    وصف الملف: application/pdf